Min Hee-jin Claims 'Shareholder Agreement Violation' After Unilateral Dismissal; Hybe Stock Rises 4%

김종효 기자 / approved : 2024-08-29 03:58:03
  • -
  • +
  • 인쇄

(Photo= Yonhap news)

[Alpha Biz= Reporter Kim Jonghyo] On August 28, Hybe's stock showed strong performance, rising 4.07% to 184,000 won compared to the previous day. During trading, the stock peaked at 184,500 won, demonstrating its strength.


The day before, Hybe's subsidiary, ADOR, announced the dismissal of former CEO Min Hee-jin and the appointment of Kim Joo-young as the new CEO.

ADOR stated that Min Hee-jin would continue to serve as an internal director and remain involved in producing roles.

However, Min Hee-jin criticized the dismissal as unilateral and indicated the possibility of legal action. She argued that the decision violated the shareholder agreement and the prohibition on voting rights, and claimed that the board's decision to continue assigning her producing duties was made without proper consultation.

Meritz Securities analyst Kim Min-young commented that ADOR’s decision deviates from the multi-label operation principle traditionally applied across all labels, with the CEO directly overseeing production and management. He noted that the decision followed legal procedures but acknowledged that risks related to legal verification and potential additional lawsuits have not been completely resolved. Nonetheless, he positively assessed the organizational improvements achieved through the separation of production and management.

 

 

 

Alphabiz 김종효 기자(kei1000@alphabiz.co.kr)

어플

주요기사

Bomb Threats Target Major Korean Companies Including Samsung Electronics2025.12.19
FSS Raises Consumer Alert to “Warning” Over Secondary Scams Linked to Coupang Data Breach2025.12.19
Final U.S. Defense Authorization Bill Omits Provisions Supporting South Korea-Japan Shipbuilding Cooperation2025.12.19
Controversy Surrounds KT’s Former Outside Director Cho Seung-ah Amid Dual Directorship Issue2025.12.19
Samsung Securities Lowers LG Energy Solution Target Price to KRW 480,000 Amid Contract Cancellations2025.12.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사